Sheila R. Gibson focuses her practice on intellectual property transactions, with an emphasis on intellectual property portfolio strategy and management, including domestic and international patent protection in the biotechnology, medical device, mechanical, environmental, pharmaceutical, nutraceutical and related industries.
At Hahn Loeser
Her practice also includes counseling and opinion work related to patentability, right-to-practice and product-launch, investor due diligence and licensing. Ms. Gibson's technical emphasis is in biotechnology (microbiology and molecular genetics, immunology, cellular biology, molecular biology and pharmaceuticals); medical devices and procedures (diagnostics, sensors and instrumentation); and environmental technology (clean and alternative energies).
University of California, Los Angeles B.S., Microbiology & Molecular Genetics 1996
University of Southern California School of Law J.D. 2002
State of California
U.S. Patent and Trademark Office